MedPath

The effect of synbiotic supplementation on patients with metabolic syndrome

Not Applicable
Recruiting
Conditions
Metabolic syndrome.
Metabolic disorder, unspecified
E88.9
Registration Number
IRCT20140208016529N4
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

Willingness to participate in projects
Women and men aged 20-55 years
Waist circumference =88 cm in women and waist circumference =102 cm in men, serum triglyceride =150 mg/dl, serum HDL cholesterol <40 mg/dl in men and <50 mg/dl in women, fasting blood glucose =100 mg/dl
body mass index > 25 kg/m2

Exclusion Criteria

History of mental disease, cancer, cardiovascular disease, thyroid, pulmonary,renal and hepatic problems and eating disorders
Pregnant,lactating and post-menopausal women
Participating in weight loss or weight gain programs three months before the intervention
Taking any dietary supplements, probiotics, prebiotic, synbiotic food products, and antibiotics two months before the intervention
Taking drugs that affect appetite and body weight,and anti-inflammatory drugs
History of allergies to probiotics , prebiotics and maltodextrin products

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting Blood Sugar. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Colorimetric method.;Serum insulin. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: ELISA.;Homeostasis model assessment of insulin resistance (HOMA-IR). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Equation.;Quantitative Insulin Sensitivity Check Index(QUICKI). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Equation.
Secondary Outcome Measures
NameTimeMethod
High Sensitivity C-Reactive Protein. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Biochemical method.;Tumor Necrosis Factor-Alpha (TNF-a). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: ELISA.;Appetite. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Visual Analogue Scale.;Energy content of food. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Food record questionnaire.;Physical activity energy expenditure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Metabolic equivalent of tasks questionnaire.
© Copyright 2025. All Rights Reserved by MedPath